Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.65% | 124.58% | -21.53% | 1,081.63% | -90.55% |
| Total Depreciation and Amortization | -0.66% | -0.82% | 20.58% | -21.51% | 559.25% |
| Total Amortization of Deferred Charges | 5.41% | -2.63% | -2.56% | 77.27% | -- |
| Total Other Non-Cash Items | 70.61% | -62.55% | 87.88% | -20,485.00% | -81.82% |
| Change in Net Operating Assets | 500.33% | -497.39% | -97.15% | 3,353.23% | -108.77% |
| Cash from Operations | 78.70% | 42.65% | -52.50% | 343.81% | -67.84% |
| Capital Expenditure | -- | 100.00% | 71.43% | 99.99% | -727,354.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 71.43% | 99.99% | -727,354.55% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | 19.98% | -19,739.47% | -8.57% | 33.96% | -265.52% |
| Issuance of Common Stock | 350.00% | -67.74% | 106.67% | 50.00% | -58.33% |
| Repurchase of Common Stock | 26.27% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 87.69% | -- |
| Cash from Financing | 20.98% | -38,146.67% | 56.73% | -100.26% | 790,220.00% |
| Foreign Exchange rate Adjustments | -123.02% | 5,400.00% | 97.83% | -986.54% | 125.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 72.66% | -356.09% | -49.92% | 121.61% | -740.68% |